BOK Financial’s Kite Pharma, Inc. KITE Stock Holding History

BOK Financial’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-21,035	Closed	-$3.78M	–	1168
2017 Q3	$3.78M	Sell	21,035 -5,852	-22%	-$815K	0.11%	211
2017 Q2	$2.79M	Buy	26,887 +165	+0.6%	+$13.5K	0.09%	247
2017 Q1	$2.1M	Buy	26,722 +176	+0.7%	+$10.9K	0.07%	307
2016 Q4	$1.19M	Buy	+26,546	New	+$1.3M	0.04%	424
2015 Q2	–	Sell	-3,820	Closed	-$220K	–	908
2015 Q1	$220K	Buy	+3,820	New	+$256K	0.01%	757

BOK Financial's KITE Position: Q4 2017 in Review

BOK Financial sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 21,035 shares — an estimated $3.78M sold.

BOK Financial first reported a position in KITE in Q1 2015 and held it in 5 quarters. The position peaked at $3.78M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

BOK Financial reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
BOK Financial sold 21,035 Kite Pharma, Inc. shares in Q4 2017, an estimated $3.78M.
BOK Financial first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 5 quarters.
BOK Financial's Kite Pharma, Inc. position peaked at $3.78M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on BOK Financial's 13F filing for Q4 2017, filed 14 Feb 2018.